⌘K

Home/Filings/4/0000874015-25-000189

4//SEC Filing

BENNETT C FRANK 4

Accession 0000874015-25-000189

CIK 0000874015other

View on SEC.gov Company Profile

Filed

Sep 2, 8:00 PM ET

Accepted

Sep 3, 6:29 PM ET

Size

4.9 KB

Accession

0000874015-25-000189

Insider Transaction Report

Form 4

Period: 2025-08-29

IONIS PHARMACEUTICALS INCIONS

BENNETT C FRANK

EVP, Chief Scientific Officer

Transactions

Other
Common Stock
2025-08-29$27.71/sh+213$5,902→ 93,679 total

Footnotes (1)

[F1]Reporting shares purchased under the Ionis Pharmaceuticals, Inc. Amended and Restated 2000 Employee Stock Purchase Plan on August 29, 2025. These shares may not be sold until March 2, 2026.

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT

Issuer

IONIS PHARMACEUTICALS INC

CIK 0000874015

Entity typeother

IncorporatedDE

Related Parties

1

filerCIK 0001073387

Filing Metadata

Form type: 4
Filed: Sep 2, 8:00 PM ET
Accepted: Sep 3, 6:29 PM ET
Size: 4.9 KB

View on SEC.gov